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GROWTH FACTOR LEVELS I'N THE DIABETIC VITREOUS: 
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Purpose. To determine growth factor levels in individual vitrectomy samples 
from insulin-d ependent and non-insulin dependent diabetics (IDDM & NIDDM) 
and to correlate such levels with a) the type of diabetes and b) neovascular 
activity. 
Me&m! Over 70 vitreous gel samples wem obtained from diabetic patients with 
proliferative retinopathy and non-diabetic (“control”) patients undergoing 
vitrectomy. Levels of bFGF, IGF-I, EGF, TGF+Z and insulii were determined 
by radioimmunoassay. IGF-I binding, protein levels were assessed by laser 
densitometry of Western ligand blots. 
RmdtF. bFGF levels were significantly greater in vitreous samples from 
NIDDM patients than either IDDM OI non-diabetic patients. When subdivided 
into eyes with active neovascular or inactive fibrotic membranes the highest 
levels of bFGF were found in NIDDM patients with active membranes. No 
significant difference in the levels of ~the other growth factors was observed 
between the NIDDM and non-diabetic group. In the IDDM group, both IGF-I 
and a 34kDa IGF-BP were elevated compared to the other groups while TGF-p2 
levels were greatly reduced. The increase in IGF-I and IGF-BPS, and the decrease 
in TGF+2, were greatest in patients with active neovascularisation. bFGF and 
EGF levels were did not differ between the IDDM and non-diabetic groups. 
Conclwion. In proliferative diabetic rctinopathy there is a correlation between 
intravitreal growth factors and both disease type (whether IDDM or NIDDM) and 
disease state (whether active 01 fibrotic). 
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BACKGROUND: Structural changes of proteins are considered 
among the basic mechanism leading to diabetic complications. 
However, little is known about th; redox status of the vi- 
treous proteins in diabetic subjects. Therefore, the aim of 
this studv was to investigate the content of sulfhvdrvl DTO- 
t,eins (P-5H), protein mixid disulfides (PB-SH) ani carbony 
Droteins (DNPH) in the vitreous of diabetic and non diabetic 
jubjects.. 
METHODS: 27 subjects were included III the study (A=7 healthy 
controls, B=lO type-2 diabetic subjects affected by prolifera- 
tive retinopathy; C=lO type-2 diabetic subjects affected by 
non-proliferative retinopathy). After suction the vitreous was 
cont;ifuged and the super&ant analyzed for PB-SH and 
DNPH, indices of oxidatively demaged proteins, and P-SH, 
index of reduced status of the proteins. 
RESULTS: A significant lower content of P-SH was found in 
the vitreous of diabetic subjects (9.7;+2.4 vs 17+5.L nmol/mg 
prot, p O.OOl), especially when a reti;ial complication was 
present (7.1+2.1 nmol/mg prot, p 0.02 compared to Cl. 
MoreoLer an-increased formation of PB-SH and DNPH was no- 
ticed in diabetic subjects compared to healthy controls 
(‘P 0.001.l . Yet. these parameters resulted to be particularlv 
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Purpose Localized, plasmin-mediated extracdluiar matrii pmtedyaia on tha 
swiace of vascular endothdial celfs is an knpwtant feature of angfogwesfs. We 
report on the expression and kwliiation of plasminogen actiiatws, theii inhibitors 
and cell surface receptors by human retinal endolhdii celfs. 
Methods Retiiae were homogenised, incubated with cdlagenase. and 
cultured on libronectin coated plastic. Plasminogen activators and their inhibitors 
were detected in endothelird cell culture supematants by SDS-PAGE with 
zymography using fibrin-agarose plates. These proteins were quantified by spedfii 
ELBA. The proteins were detected on cdl cufture nwdayer~ by 
immwxytochemistry wing alkaline phcspimtase and by immunoflwrescence 
with scanning laser confocal microszopy and conventional lluowcenw 
mkroacopy. Expression at the lewl of mRNA was studied by PCR using specific 
primers. 
Results Hunw retinal endotfwlial cdl mondayers stained positively for 
plasm- activator inhibitor-1 (PAI-1). urokinase type plaemkwgen activator 
(U-PA), u-PA receptor, tissue type plasminogen adfvatar (I-PA) and plasmkwgen 
activator ir&iir-2 (PAM). mRNA IQ u-PA w#d PAI-I was detected. Cell c&lure 
supematants contained in the range of lOO”glml PAI-1, long/ml u-PA and 1 rig/ml 
t-PA. 
Conclusions The% results suggest that plasmin generation could occur on the 
cell surface but would be limhad in the fluid phase. Regulation of plasmincgen 
adlvatim by wdothdii calls is akical in angfcge”esfs and thfs system offers the 
potential to charac+wise these mechani%ns and their role in the dwdopment of 
retinal “eovascularisation. 
altered when diabetes &as associated with retina< disease. . 
CONCLUSIONS: This study shows an alteration of the protein 
redox status in subjects affected by diabetes mellitus. Vi- 
treous proteins were found to be oxidized to a larger extent 
in the presence of retinal disease. 
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